Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

William Paul

William Paul, M.D., is the NIH Distinguished Investigator and Chief of the Laboratory of Immunology within the National Institute of Allergy and Infectious Diseases (NIAID). Paul discovered and characterized the cell signaling cytokine IL-4, demonstrating that IL-4 is required for B cell production of IgE, and determined the requirements for CD4+ T cell differentiation. In an interview with JCI Editor-at-Large Ushma Neill, Paul discusses his early research experiences, as well as the influence of Michael Heidelberger on his decision to study immunology. Paul began his training in immunology in Nobel laureate Baruj Benacerraf’s lab at New York University and then moved with Bennacerraf to the NIH in 1968, where he began to focus on T and B cell biology. His lab has served as a training ground for many noted immunologists, including Laurie Glimcher, Mark Davis, and Charlie Janeway.

Published April 1, 2015, by The JCI

Conversations with Giants in Medicine

Related articles

A conversation with Bill Paul
Ushma S. Neill
Ushma S. Neill
Published April 1, 2015
Citation Information: J Clin Invest. 2015;125(4):1367-1368. https://doi.org/10.1172/JCI81730.
View: Text | PDF
Conversations with Giants in Medicine

A conversation with Bill Paul

  • Text
  • PDF
Abstract

Authors

Ushma S. Neill

×
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts